Show simple item record

dc.contributor.authorGarcia, Paulo A.
dc.contributor.authorKos, Bor
dc.contributor.authorRossmeisl, John H. Jr.
dc.contributor.authorPavliha, Denis
dc.contributor.authorMiklavčič, Damijan
dc.contributor.authorDavalos, Rafael V.
dc.date.accessioned2017-11-22T13:54:01Z
dc.date.available2017-11-22T13:54:01Z
dc.date.issued2017-07-25
dc.identifier.urihttp://hdl.handle.net/10919/80476
dc.description.abstractPurpose: Irreversible electroporation (IRE) has been developed as a promising minimally invasive treatment to ablate spontaneous brain tumors with pulsed electric fields in canine patients. The purpose of the study is to determine the Peleg-Fermi parameters needed to incorporate pulse number and pulse duration into the therapeutic planning of IRE. Methods: Seven canine patients were treated with IRE for spontaneous malignant glioma with MRIbased treatment planning. The treatment planning method consists of building patient-specific finite element models and using them to compute electric fields used in the IRE treatment. We evaluate the predictive power of tumor coverage with electric field alone vs. cell kill probability using radiographically confirmed clinical outcomes. Results: Results of post-treatment diagnostic imaging, tumor biopsies, and neurological examinations indicated successful tumor ablation without significant direct neurotoxicity in six of the seven dogs. Objective tumor responses were seen in four (80%) of five dogs with quantifiable target lesions according to RANO criteria. Two dogs experienced survivals in excess of 1 yr, including one dog that resulted in complete response to IRE treatment for 5+ years to date. Tumor fraction exposed to electric field over 600 V/cm was between 0.08 and 0.73, while tumor fraction exposed to electric field over 300 V/cm was between 0.17 and 0.95. Probability of cell kill of ≥ 90% was found in tumor volume fractions between 0.21 and 0.99. Conclusions: We conclude that IRE is a safe and effective minimally invasive treatment for malignant glioma and can be predicted with the Peleg-Fermi cell kill probability function. A tumor coverage of ≥ 0.9 at a cell kill probability ≥ 90% can be used to guide IRE treatments of spontaneous malignant glioma based on the radiographically confirmed clinical outcomes achieved.en_US
dc.description.sponsorshipThis work was supported by the Wallace H. Coulter Foundation Early Career Translational Research Awards and the National Science Foundation CBET-0933335 and CAREER CBET-1055913. This research was supported in part by the Slovenian Research Agency (Grants BI-US/14-15-016, P2- 0249 and Z3-7126). It has been performed within the scope of LEA EBAM. The study was made possible due to networking efforts of the COST TD1104 action (www.electropo ration.net). AngioDynamics, Inc. loaned the NanoKnife System and manufactured the electrodes used in the study (www.angiodynamics.com).en_US
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectbrain tumoren_US
dc.subjectminimally invasiveen_US
dc.subjectneurosurgeryen_US
dc.subjectpulsed electric fieldsen_US
dc.subjecttreatment planningen_US
dc.titlePredictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant gliomaen_US
dc.typeArticle - Refereeden_US
dc.title.serialMedical Physicsen_US
dc.identifier.doihttps://doi.org/10.1002/mp.12401
dc.identifier.volume44en_US
dc.identifier.issue9en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial 3.0 United States
License: Attribution-NonCommercial 3.0 United States